The largest database of trusted experimental protocols

Amicon ultra 15 100 kda

Manufactured by Merck Group
Sourced in United States, Ireland

The Amicon® Ultra-15-100 kDa is a centrifugal filter device designed for the concentration and purification of macromolecules such as proteins, peptides, and nucleic acids. It features a 100 kDa molecular weight cut-off membrane that allows the passage of smaller molecules while retaining the target macromolecules.

Automatically generated - may contain errors

9 protocols using amicon ultra 15 100 kda

1

Quantification of Conditioned Media HA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conditioned medium (15 mL) was harvested from MEF and MEF-Has3-KO cells cultured by standard protocols for 24 h. After that, samples with different MW cutoffs were concentrated according to the standard protocol by using the following ultracentrifugal filters: Amicon® Ultra-15-100 kDa (UFC910008, Merck Millipore, Burlington, MA, USA), Amicon® Ultra-15-50 kDa (UFC905008, Merck Millipore, Burlington, MA, USA), Amicon® Ultra-15-30 kDa (UFC903008, Merck Millipore, Burlington, MA, USA), and Amicon® Ultra-15-3 kDa (UFC900308, Merck Millipore, Burlington, MA, USA). The concentration of HA (ng/mL) in concentrated samples was determined by using an HA ELISA-like assay [14 (link)].
+ Open protocol
+ Expand
2

Urine Extracellular Vesicle Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
UF-SEC was performed according to the protocol by Monguió-Tortajada et al. [32 (link)] with some minor modifications. Ten mL of pre-processed urine was centrifuged at 17,000× g for 15 min at 4 °C. The supernatant was then supplemented with 5 mL of 0.9% NaCl and concentrated by centrifugation (4000× g; 10 min; room temperature) using Amicon Ultra-15,100 kDa centrifugal filtration units (regenerated cellulose; Merck/Millipore, Cork, Ireland). To further reduce the protein content, the concentrate above the filter was diluted with 0.9% NaCl to a final volume of 10 mL and re-concentrated by centrifugation. Concentrates were harvested and supplemented with 0.9% NaCl to a final volume of 1 mL. Thereafter, SEC was performed as described above.
+ Open protocol
+ Expand
3

Extracellular Vesicle Fractionation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
10,000 x g supernatant was loaded into a HiPrep 26/60 Sephacryl S-500 HR prepacked gel filtration column (GE Healthcare Life Sciences), which contains a hydrophilic, rigid allyl dextran/bisacrylamide matrix with a bed height/volume of 600 mm/120 ml, and eluted with 4.84 mM EDTA/DPBS at a flow rate of 1.5 ml/min. For TEM and nanoparticle tracking analysis (see the following text), EV-containing SEC fractions were assessed without concentration, unless specified otherwise. Where indicated, SEC fractions were concentrated by ultracentrifugation at 100,000 x g (avg) (36,900 RPM, k-Factor = 157) in a 70 Ti rotor for 90 min at 4°C, and pellets were resuspended either in lysis buffer containing a protease inhibitor cocktail for gel electrophoresis and western blot analysis, or in 4.84 mM EDTA/DPBS for TEM (see below). Alternatively, for some experiments, SEC fractions were concentrated via ultrafiltration by passing SEC fractions through an Amicon Ultra-15 100 kDa cellulose ultrafiltration device (Merck Millipore), according to the manufacturer’s instructions. Protein content was measured by Pierce BCA Protein Assay (ThermoFisher).
+ Open protocol
+ Expand
4

Exosome Isolation from Conditioned Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured in conditioned medium containing 10% exosome-depleted FBS for 72 h at 90–100% density. The conditioned medium was harvested and centrifuged at 2,000 × g for 10 min followed by 10,000 × g for 30 min at 4°C. Then, the supernatant was filtered using a 0.22-µm filter to eliminate cellular debris thoroughly and concentrated using centrifugal ultrafiltration (Amicon® Ultra-15 100 KDa; Merck KGaA) to minimize the potential contamination, respectively.
Exosomes were isolated from processed conditioned medium with Ribo™ Exosome Isolation Reagent (Guangzhou RiboBio Co., Ltd., Guangzhou, China), according to the manufacturer's instructions. Briefly, processed conditioned medium was mixed with Ribo™ Exosome Isolation Reagent at a ratio of 3:1 and incubated at 4°C overnight. After centrifugation at 1,500 × g for 30 min, exosomes pellets were resuspended in appropriate phosphate-buffered saline (PBS; HyClone; GE Healthcare Life Sciences) for TEM, NTA and further research. The exosome pellets were used immediately or stored at −80°C until use.
+ Open protocol
+ Expand
5

Exosome Isolation from Cultured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified CAFs and NFs were cultured in BEGM medium (containing 10% exosome‐depleted FBS) for 72 h. When each cell monolayer was near confluence, the culture supernatant was collected and centrifuged (1500 g, 10 min), followed by centrifugation (10,000 g, 30 min) at 4°C. The resulting exosome supernatant was then filtered (0.22 μm filter) to eliminate cellular debris, followed by centrifugal ultrafiltration (Amicon® Ultra‑15 100 KDa; Merck KGaA) to prevent potential contamination. Exosomes were isolated from the ultrafiltered supernatant with Ribo™ Exosome Isolation Reagent (RiboBio Co., Ltd.), as previously described.15 Briefly, the collected conditioned medium was mixed with Ribo™ Exosome Isolation Reagent (ratio 3:1), followed by an incubation at 4°C overnight. The medium was then centrifuged (1500 g, 30 min), and the resulting exosome pellets were suspended in phosphate‑buffered saline (PBS; HyClone; GE Healthcare Life Sciences) and analysed immediately or stored at −80°C for subsequent research.
+ Open protocol
+ Expand
6

Urine Extracellular Vesicle Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
UF-SEC was performed according to the protocol by Monguió-Tortajada et al. (32) with some minor modifications. 10 mL of pre-processed urine was spun at 17,000 x g for 15 minutes at 4°C. The supernatant was then supplemented with 5 mL of 0.9% NaCl and concentrated by centrifugation (4,000 x g; 10 min; room temperature) using Amicon Ultra-15 100 kDa centrifugal filtration units (regenerated cellulose; Merck/Millipore, Cork, Ireland). To further reduce the protein content, the concentrate above the filter was diluted with 0.9% NaCl to a final volume of 10 mL and re-concentrated by centrifugation. Concentrates were harvested and supplemented with 0.9% NaCl to a final volume of 1 mL. Thereafter, SEC was performed applying the same protocol than for UC-SEC and PEG-SEC.
+ Open protocol
+ Expand
7

Purification and Labeling of Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
CM was pre-cleared first by a low-speed centrifugation step (500 × g for 10 min) followed by centrifugation at 2,000 × g for 10–20 min to remove larger particles and debris. Unless indicated otherwise, samples were subsequently filtered through a syringe filter (VWR) or bottle top filters (Corning, low protein binding) with cellulose acetate membrane with a 0.22 µm pore size to remove any remaining larger particles. The CM was then ultra-filtrated either using Amicon Ultra-15 100 kDa (Millipore) spin filter at 4000 x g for 30 min or using tangential flow filtration (MicroKross, 20 cm2, SpectrumLabs) with a cut-off of 300 kDa to concentrate the CM. In some experiments, the concentrated retentate was further purified by size exclusion chromatography column (iZON biosciences) according to the manufacturer’s instruction to further purify the EVs.
For DiR labelling, filtered CM was incubated with 1 µM fluorescent lipophilic tracer DiR (1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide) (D12731, Invitrogen, Life Technologies) at room temperature (RT) for 30 min prior to EV isolation by ultracentrifugation at 120,000 x g for 70 min (Beckman coulter).
+ Open protocol
+ Expand
8

Isolation and Characterization of Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
To produce the EVs for in vivo injection, the corresponding stable cells were seeded in 15‐cm dishes with 10 million cells/ dish with full DMEM medium. Two days late, the medium was changed to Opti‐MEM medium (Gibco, USA) with 1% Anti‐anti. And then the conditional medium (CM) was harvested 48 h late, serially centrifuged at 700 × for 5 min and 2000× g at 4°C for 10 min. The CM was filtered with bottle top filters system (Corning, low protein binding) with cellulose acetate membrane. This system contains a 0.22 μm pore size within the membrane and can remove the remaining larger particles. The EVs in the filtered CM were isolated with Tangential flow filtration (TFF, MicroKross, 20 cm2, Spectrum labs). The cut‐off of TFF is 300 kDa and the particles bigger than 300 kDa are remained in the system and concentrated. And then the concentrated particles were further concentrated by Amicon Ultra‐15 100 kDa (Millipore) spin filter, centrifuged at 4000× for 30 min to several hours at 4°C depending on the amount EVs in the samples. At last, the concentrated EVs were collected in maxirecovery 1.5 ml Eppendorf tubes (Axygene, USA) and the concentrations were detected by Nanoparticle Tracking Analysis (NTA).
+ Open protocol
+ Expand
9

Glucose-Modified Gold Nanoparticle Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
GNPs were purchased from BBI Solutions (Crumlin, UK). The glucose-modified GNPs were prepared as previously described with some modifications (41 (link)-43 ). Briefly, 4 mL GNP solution was filtered through Amicon Ultra-15 100 kDa centrifugal filter devices (Millipore, Billerica, MA, USA), and ultrafiltration was carried out at 5,000 ×g for 10 min. The GNPs were then resuspended in 4 mL deionized water. This process was repeated twice to remove the excess coating of polymers in the GNP solution. Next, 200 µL 1 mM glucose-monofunctional polyethylene glycol-thiol (glucose-mPEG-SH) was added to 1 mL 0.3 mM GNP solution. The mixture was stirred for 24 h at room temperature (25 °C) and ultrafiltration was conducted as described above to remove excess glucose-mPEG-SH.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!